Indeed, a retrospective meta-analysis of 1378 early stage ERα-negative BCs and 623 TNBCs confirmed that a high tumoral GR expression was significantly correlated with a shorter relapse-free survival in BC patients, whether undergoing treated or not with adjuvant chemotherapy [96,114]. The gene discussed is ESR1; the disease is breast cancer.